NCT06514521Recruiting
Post Marketing Study on Pluvicto in Korea
A Post Marketing Surveillance on PluvictoTM (Lutetium(177Lu) Vipivotide Tetraxetan) in South Korea; An Open-label, Non-interventional, Primary Data Collection, Multi-center, Non-comparative, Non-randomized Observational Study to Assess Safety and Effectiveness of Pluvicto in Real World Setting
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
Post marketing study on Pluvicto in Korea
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 278 (estimated)
- First submitted
- 17 Jul 2024
- Start date
- 18 Apr 2025
- Primary completion date
- 31 May 2028
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Prostate cancer
- NCT number
- NCT06514521
What you commit to
- Study type: Observational
- Planned participants: 278
- From 18 Apr 2025 to the primary completion date, 31 May 2028
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Study participants meeting any of the following criteria are not eligible for inclusion in this study:
- Subject whose medical record is not accessible
- Subject who is not willing to provide the informed consent
Who the study is looking for
- Study participants eligible for inclusion in this study must meet all of the following criteria:
- Male adult patient age ≥ 18
- Subject who are being treated with Pluvicto or whose treatment plan is finalized and scheduled to be administered at the time of consent by physician in accordance with the approved indication in South Korea
- Subject who provided the written informed consent prior to the study enrollment
Age in the registry: 18 years to 100 years · Sex: Male · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Busan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Jeollanam | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Suwon | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.